CDHR1 and glioblastoma: Moreover, ROC analysis in TCGA, CGGA, GSE4412 and GSE43378 datasets showed that expression levels of CDHR1 could distinguish GBM from LGG patients with high specificity and sensitivity (Fig. 2B).